Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9524 |
High Similarity |
NPD2801 |
Approved |
0.9139 |
High Similarity |
NPD3882 |
Suspended |
0.9067 |
High Similarity |
NPD1934 |
Approved |
0.8912 |
High Similarity |
NPD1511 |
Approved |
0.8882 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8792 |
High Similarity |
NPD1512 |
Approved |
0.8625 |
High Similarity |
NPD3818 |
Discontinued |
0.8616 |
High Similarity |
NPD6166 |
Phase 2 |
0.8616 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8616 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8601 |
High Similarity |
NPD943 |
Approved |
0.8601 |
High Similarity |
NPD1240 |
Approved |
0.8581 |
High Similarity |
NPD3817 |
Phase 2 |
0.8493 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8491 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8483 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8481 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8476 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8447 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8442 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8408 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8405 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8405 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8355 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8289 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8242 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.82 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8144 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8133 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8086 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8079 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD2796 |
Approved |
0.805 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8013 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7988 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7972 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7919 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7917 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7885 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7885 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7875 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7792 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7744 |
Intermediate Similarity |
NPD919 |
Approved |
0.7712 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7703 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7661 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7548 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7547 |
Intermediate Similarity |
NPD5401 |
Approved |
0.753 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7472 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7453 |
Intermediate Similarity |
NPD920 |
Approved |
0.7452 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7439 |
Intermediate Similarity |
NPD37 |
Approved |
0.7427 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7379 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7377 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7358 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7349 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7342 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7342 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7329 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7294 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7294 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7261 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7261 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7205 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7183 |
Intermediate Similarity |
NPD228 |
Approved |
0.7181 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7181 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7179 |
Intermediate Similarity |
NPD2899 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7126 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7074 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD824 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7032 |
Intermediate Similarity |
NPD411 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7011 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7011 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.6987 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6984 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6984 |
Remote Similarity |
NPD7697 |
Approved |
0.6984 |
Remote Similarity |
NPD7698 |
Approved |
0.6983 |
Remote Similarity |
NPD8312 |
Approved |
0.6983 |
Remote Similarity |
NPD8313 |
Approved |
0.6979 |
Remote Similarity |
NPD8151 |
Discontinued |
0.697 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD1608 |
Approved |
0.6947 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD3764 |
Approved |
0.6923 |
Remote Similarity |
NPD3268 |
Approved |
0.6923 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6898 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6898 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6887 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6863
|
Remote Similarity |
NPD1876 |
Approved |